Filing Flows › Merck (MRK) › Capital expenditures
Merck (MRK) capital expenditures by quarter
Merck's capital expenditures were $1.0B in Q3 2026 (third quarter 2026), +16% from Q2 2026. Over the last 7 quarters it ranged from $764M (Q2 2025) to $1.3B (Q1 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.0B | +16% | +5% |
| Q2 2026 | $893M | -10% | +17% |
| Q1 2026 | $991M | -4% | -25% |
| Q4 2025 | $1.0B | +5% | — |
| Q3 2025 | $987M | +29% | — |
| Q2 2025 | $764M | -42% | — |
| Q1 2025 | $1.3B | — | — |
Q3 2026 at a glance
Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.
Questions
What is Merck's capital expenditures?
Merck's capital expenditures were $1.0B in Q3 2026 (third quarter 2026), +16% from Q2 2026.
How has Merck's capital expenditures changed?
Over the last 7 quarters it ranged from $764M (Q2 2025) to $1.3B (Q1 2025).